Next Article in Journal
Countercurrents: The Bias of Choice
Previous Article in Journal
Impact of the Gut Microbiome on Immune Checkpoint Inhibitor Efficacy—A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 26
Issue 6
10.3747/co.26.6145
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Current and Emerging Biomarkers in Metastatic Colorectal Cancer

by
M. K. C. Lee
and
J. M. Loree
*
BC Cancer, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(6), 404; https://doi.org/10.3747/co.26.6145
Submission received: 8 September 2019 / Revised: 5 October 2019 / Accepted: 4 November 2019 / Published: 1 December 2019

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In the initially published manuscript, the article stated (about the BEACON clinical trial) that “Interestingly, the triplet did not appear more active than the combination of encorafenib and binimetinib (mos: 9.0 months vs. 8.4 months; HR: 0.79; 95% CI: 0.59 to 1.06).” [...]

Share and Cite

MDPI and ACS Style

Lee, M.K.C.; Loree, J.M. Erratum: Current and Emerging Biomarkers in Metastatic Colorectal Cancer. Curr. Oncol. 2019, 26, 404. https://doi.org/10.3747/co.26.6145

AMA Style

Lee MKC, Loree JM. Erratum: Current and Emerging Biomarkers in Metastatic Colorectal Cancer. Current Oncology. 2019; 26(6):404. https://doi.org/10.3747/co.26.6145

Chicago/Turabian Style

Lee, M. K. C., and J. M. Loree. 2019. "Erratum: Current and Emerging Biomarkers in Metastatic Colorectal Cancer" Current Oncology 26, no. 6: 404. https://doi.org/10.3747/co.26.6145

APA Style

Lee, M. K. C., & Loree, J. M. (2019). Erratum: Current and Emerging Biomarkers in Metastatic Colorectal Cancer. Current Oncology, 26(6), 404. https://doi.org/10.3747/co.26.6145

Article Metrics

Back to TopTop